ST. PAUL, MN -- (MARKET WIRE) -- May 08, 2007 -- GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, announced today that it has signed a strategic consulting agreement with Bi-Coastal Pharmaceutical Corp., a leading Sales, Marketing and Consulting organization serving the health care industry since 1982 and headquartered in Red Bank, New Jersey.
